Epidemiology of Diphtheria in Yemen, 2017-2018: Surveillance Data Analysis.


Journal

JMIR public health and surveillance
ISSN: 2369-2960
Titre abrégé: JMIR Public Health Surveill
Pays: Canada
ID NLM: 101669345

Informations de publication

Date de publication:
02 06 2021
Historique:
received: 29 01 2021
accepted: 21 03 2021
revised: 20 03 2021
entrez: 2 6 2021
pubmed: 3 6 2021
medline: 6 11 2021
Statut: epublish

Résumé

As a consequence of war and the collapse of the health system in Yemen, which prevented many people from accessing health facilities to obtain primary health care, vaccination coverage was affected, leading to a deadly diphtheria epidemic at the end of 2017. This study aimed to describe the epidemiology of diphtheria in Yemen and determine its incidence and case fatality rate. Data were obtained from the diphtheria surveillance program 2017-2018, using case definitions of the World Health Organization. A probable case was defined as a case involving a person having laryngitis, pharyngitis, or tonsillitis and an adherent membrane of the tonsils, pharynx, and/or nose. A confirmed case was defined as a probable case that was laboratory confirmed or linked epidemiologically to a laboratory-confirmed case. Data from the Central Statistical Organization was used to calculate the incidence per 100,000 population. A P value <.05 was considered significant. A total of 2243 cases were reported during the period between July 2017 and August 2018. About 49% (1090/2243, 48.6%) of the cases were males. About 44% (978/2243, 43.6%) of the cases involved children aged 5 to 15 years. Respiratory tract infection was the predominant symptom (2044/2243, 91.1%), followed by pseudomembrane (1822/2243, 81.2%). Based on the vaccination status, the percentages of partially vaccinated, vaccinated, unvaccinated, and unknown status patients were 6.6% (148/2243), 30.8% (690/2243), 48.6% (10902243), and 14.0% (315/2243), respectively. The overall incidence of diphtheria was 8 per 100,000 population. The highest incidence was among the age group <15 years (11 per 100,000 population), and the lowest incidence was among the age group ≥15 years (5 per 100,000 population). The overall case fatality rate among all age groups was 5%, and it was higher (10%) in the age group <5 years. Five governorates that were difficult to access (Raymah, Abyan, Sa'ada, Lahj, and Al Jawf) had a very high case fatality rate (22%). Diphtheria affected a large number of people in Yemen in 2017-2018. The majority of patients were partially or not vaccinated. Children aged ≤15 years were more affected, with higher fatality among children aged <5 years. Five governorates that were difficult to access had a case fatality rate twice that of the World Health Organization estimate (5%-10%). To control the diphtheria epidemic in Yemen, it is recommended to increase routine vaccination coverage and booster immunizations, increase public health awareness toward diphtheria, and strengthen the surveillance system for early detection and immediate response.

Sections du résumé

BACKGROUND
As a consequence of war and the collapse of the health system in Yemen, which prevented many people from accessing health facilities to obtain primary health care, vaccination coverage was affected, leading to a deadly diphtheria epidemic at the end of 2017.
OBJECTIVE
This study aimed to describe the epidemiology of diphtheria in Yemen and determine its incidence and case fatality rate.
METHODS
Data were obtained from the diphtheria surveillance program 2017-2018, using case definitions of the World Health Organization. A probable case was defined as a case involving a person having laryngitis, pharyngitis, or tonsillitis and an adherent membrane of the tonsils, pharynx, and/or nose. A confirmed case was defined as a probable case that was laboratory confirmed or linked epidemiologically to a laboratory-confirmed case. Data from the Central Statistical Organization was used to calculate the incidence per 100,000 population. A P value <.05 was considered significant.
RESULTS
A total of 2243 cases were reported during the period between July 2017 and August 2018. About 49% (1090/2243, 48.6%) of the cases were males. About 44% (978/2243, 43.6%) of the cases involved children aged 5 to 15 years. Respiratory tract infection was the predominant symptom (2044/2243, 91.1%), followed by pseudomembrane (1822/2243, 81.2%). Based on the vaccination status, the percentages of partially vaccinated, vaccinated, unvaccinated, and unknown status patients were 6.6% (148/2243), 30.8% (690/2243), 48.6% (10902243), and 14.0% (315/2243), respectively. The overall incidence of diphtheria was 8 per 100,000 population. The highest incidence was among the age group <15 years (11 per 100,000 population), and the lowest incidence was among the age group ≥15 years (5 per 100,000 population). The overall case fatality rate among all age groups was 5%, and it was higher (10%) in the age group <5 years. Five governorates that were difficult to access (Raymah, Abyan, Sa'ada, Lahj, and Al Jawf) had a very high case fatality rate (22%).
CONCLUSIONS
Diphtheria affected a large number of people in Yemen in 2017-2018. The majority of patients were partially or not vaccinated. Children aged ≤15 years were more affected, with higher fatality among children aged <5 years. Five governorates that were difficult to access had a case fatality rate twice that of the World Health Organization estimate (5%-10%). To control the diphtheria epidemic in Yemen, it is recommended to increase routine vaccination coverage and booster immunizations, increase public health awareness toward diphtheria, and strengthen the surveillance system for early detection and immediate response.

Identifiants

pubmed: 34076583
pii: v7i6e27590
doi: 10.2196/27590
pmc: PMC8209531
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e27590

Informations de copyright

©Suaad Ameen Moghalles, Basher Ahmed Aboasba, Mohammed Abdullah Alamad, Yousef Saleh Khader. Originally published in JMIR Public Health and Surveillance (https://publichealth.jmir.org), 02.06.2021.

Références

Emerg Infect Dis. 2012 Feb;18(2):217-25
pubmed: 22304732
Emerg Infect Dis. 1998 Oct-Dec;4(4):539-50
pubmed: 9866730
Eur J Epidemiol. 1995 Feb;11(1):107-17
pubmed: 7489768
Bull World Health Organ. 1985;63(2):287-93
pubmed: 3874714
Epidemiol Infect. 2015 Mar;143(4):791-8
pubmed: 25703400
Lancet Glob Health. 2016 Jul;4(7):e451
pubmed: 27340001
Indian J Community Med. 2010 Jul;35(3):436-8
pubmed: 21031115
PLoS One. 2021 Feb 4;16(2):e0246301
pubmed: 33539453
Int J Infect Dis. 2014 Feb;19:74-8
pubmed: 24295558
J Infect Dis. 2000 Feb;181 Suppl 1:S2-9
pubmed: 10657184
Am J Public Health. 1985 Dec;75(12):1393-7
pubmed: 4061710
Epidemiol Infect. 2014 Apr;142(4):797-802
pubmed: 23866913

Auteurs

Suaad Ameen Moghalles (SA)

Yemen Field Epidemiology Training Programme, Ministry of Public Health and Population, Sana'a, Yemen.

Basher Ahmed Aboasba (BA)

Yemen Field Epidemiology Training Programme, Ministry of Public Health and Population, Sana'a, Yemen.

Mohammed Abdullah Alamad (MA)

Yemen Field Epidemiology Training Programme, Ministry of Public Health and Population, Sana'a, Yemen.

Yousef Saleh Khader (YS)

Department of Community Medicine, Public Health and Family Medicine, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH